The downgrade by a major analyst like JP Morgan, accompanied by a substantial decrease in the price target, is likely to negatively impact investor sentiment and the stock price of CVRx in the short term. Such a significant adjustment suggests a reassessment of the company's future growth prospects or operational performance, which could lead to a decrease in stock price as the market adjusts to the new valuation.